🇺🇸 FDA
Patent

US 7208313

Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector

granted A61KA61K2039/5156A61K48/00

Quick answer

US patent 7208313 (Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/5156, A61K48/00